Global Mtor Inhibitors Market Size 2024, Forecast To 2033
6 Mar, 2024
The mtor inhibitors market size has grown strongly in recent years. It will grow from $7.11 billion in 2023 to $7.52 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to oncology treatment advancements, renal cell carcinoma treatment, transplantation medicine, clinical research and drug development, immunosuppressive applications. The mtor inhibitors market size is expected to see strong growth in the next few years. It will grow to $9.3 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. Major trends in the forecast period include exploration of neuroprotective effects, utilization in transplant medicine, rising interest in metabolic disorders, collaborations for drug development, global health initiatives for rare diseases.
Global mTOR Inhibitors Market Key Driver
The rise in the prevalence of kidney diseases is expected to propel the growth of the mTOR inhibitors market going forward. Kidney disease refers to a condition that causes the organs to gradually deteriorate and lose their ability to function. mTOR inhibitors are used in the treatment of various kidney illnesses. Immunosuppressive treatments, including mTOR inhibitors such as sirolimus and everolimus are used to prevent renal allograft rejection. As the prevalence of kidney diseases continues to rise globally, the demand for mTOR inhibitors is increasing. For instance, in April 2022, according to the International Society of Nephrology, a US-based global professional association, there are 843.6 million people worldwide who are affected by stages 1 to 5 of kidney diseases. Over 800 million people globally or 10% of the overall population suffer from chronic renal disease, a degenerative ailment. Therefore, the rise in the prevalence of kidney diseases will propel the growth of the mTOR inhibitors market. The market size of the mTOR inhibitors market in 2023 was [insert 2023 market size], and it is projected to reach [insert 2024 market size] by 2024 and [insert 2028 market size] by 2028.
Get A Free Sample Of The Global mTOR Inhibitors Market ReportGlobal mTOR Inhibitors Market Segments
The mtor inhibitors market covered in this report is segmented –
1) By Product Type: Rapamune, Afinitor, Torisel, Zortress, Other Product Types
2) By Indication: Oncology, Immunosuppressant, Organ Transplantation, Other Indications
3) By Route of Administration: Oral, Intravenous
4) By Application: Tumor Treatment, Kidney Transplant, Other Applications
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography:The regions covered in the mtor inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the mTOR inhibitors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mtor inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major mTOR Inhibitors Industry Players
Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals plc, LC Laboratories, Exelixis Inc., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Accord Healthcare Inc., Par Pharmaceutical, AbbVie Inc., GlaxoSmithKline plc, Biocon Limited, Alkem Laboratories Ltd., Gland Pharma Ltd., Apotex Inc., Glenmark Pharmaceuticals Ltd., AstraZeneca plc, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co. Inc., AmpliPhi Biosciences Corporation, Melinta Therapeutics Inc., Aduro Biotech Inc., Cumberland Pharmaceuticals Inc., Nabriva Therapeutics plc, Paratek Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Celgene Corporation
Get The Full Global mTOR Inhibitors Market Report
mTOR Inhibitors Market Overview
mTOR inhibitors refer to a class of drugs that inhibits the mTOR (mammalian/mechanistic target of rapamycin) protein, which aids in regulating cell division. The activity of mTOR is to stop the proliferation of cancer cells and prevent the development of new cells required for tumor growth.
mTOR Inhibitors Global Market Report 2023 provides data on the global mtor inhibitors market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The mtor inhibitors market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.